Stort tack till Almi Uppsala för allt stöd ni ger oss! Läs nedan ⬇️ hur Almi kan hjälpa er! ⭐️🌟⭐️🌟⭐️🌟⭐️🌟⭐️
Läs om tre olika företag i vår artikel om hur RES (Regional Export Samverkan) är en tillgång för bolag som ska internationalisera. 👇🏻
Readily Diagnostics
Medicinska och diagnostiska laboratorier
Uppsala, Uppsala County 870 följare
Developing rapid diagnostics
Om oss
Readily Diagnostics develops sensitive, specific and rapid diagnostic testing for infectious disease. The company was founded 2022 based on research done by Dr Liza Löf, PhD in molecular medicine in Professors Masood Kamali-Moghaddam and Ulf Landegrens laboratories at the Department if Immunology, Genomics and Pathology at Uppsala University.
- Webbplats
-
www.readilydiagnostics.com
Extern länk för Readily Diagnostics
- Bransch
- Medicinska och diagnostiska laboratorier
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Uppsala, Uppsala County
- Typ
- Privatägt företag
Adresser
-
Primär
Få vägbeskrivning
Husargatan 3
D7:5
Uppsala, Uppsala County 752 37, SE
Anställda på Readily Diagnostics
Uppdateringar
-
Idag smäller det! SKAPA-pris finalen i Stockholm. Vi håller tummarna för vår Liza!
Den 14 november är det dags för årets vinnare av SKAPA-priset i Uppsala län, Liza Löf och Readily Diagnostics, att ställa upp i den nationella SKAPA-tävlingen i Stockholm. Stort lycka till!
-
Liza is at Norrsken in Barcelona! Contact Liza if you want to hear more about the solution to make diagnostics Readily available
Amazing meetings and lots of potential collaborations at Norrsken summit in beautiful Barcelona. Such a treat to be here and talk to so many incredible people! Impact entrepreneurs, impact investors and impact projects! At Readily Diagnostics we want to make a huge impact in diagnostics! As nearly half of the world’s population lacks access to diagnostics, we strongly believe we can help with our diagnostics platform for infectious disease! #infectiousdisease #antibioticresistance #diagnostics
-
-
🌟 Super Exciting News Indeed! 🌟 Vinnova is funding our innovative project! We can now accelerate one of our production ideas together with Testa Center. We are so excited about this opportunity! 🌟
Nu ger vi 13 life science-företag möjlighet till nya samarbeten för att snabba på sin utveckling av mer träffsäker diagnostik och behandling, så kallad precisionsmedicin. Satsningen innebär stöd för att samarbeta med forskningsinfrastrukturer där företagen får tillgång till sådant som kvalificerad kompetens, avancerade metoder och spjutspetsteknik. Syftet är att snabba på innovationsarbetet i företagen så att nya lösningar snabbare kommer till klinisk prövning, ut i vården och når fler patienter. Läs mer om satsningen på vår webbplats: https://lnkd.in/d6bkJ3GM
-
-
We are very happy to announce the successful closure of a €1.6 M capital round! The capital round was led by founders and existing shareholders, now joined by new investors. The funds raised will play a crucial role in expanding operations for product development and advancing production in the mission to bring accessible infectious disease testing to health care and accelerate commercialization, with the aim to make infectious disease diagnostics readily and widely available, “We are very pleased to secure this funding as a show of confidence from our investors. It will enable us to now build our in-house production of a cutting-edge diagnostic test, and to bring it to the market faster” says Liza Löf, CEO of Readily. “I am very grateful to our new as well as existing investors for their trust and support.” Read the full Press Release https://lnkd.in/dnFaNwed
Press release Readily closes capital round
readily.se
-
Liza Löf (Mokvist) will present our technology at the Microfludics Consortium in Stockholm!
I just registered for Microfluidics Consortium Open Day 2024 : Stockholm Sweden, and would love for you to join me! You can register for this event on RingCentral Events here
Microfluidics Consortium Open Day 2024 : Stockholm Sweden
events.ringcentral.com
-
We are extremely happy and proud to announce that Anna-Karin Roberto has joined Readily Diagnostics as Director of Quality & Regulatory Affairs! With over 15 years of experience in the medical device industry, specializing in quality assurance and regulatory compliance, and having held senior roles at companies like Galderma, Anna-Karin brings invaluable expertise to our team. "Anna-Karin brings not only extensive experience in quality and regulatory affairs but also valuable insights and expertise from early-stage companies and products. Her positive attitude and curiosity are fantastic attributes!" says CEO Liza Löf. Anna-Karin joined the team September 30, 2024 and will be based at the main office at Uppsala. "I'm drawn to Readily Diagnostics' exciting products, which have great potential to add significant value to healthcare and patients," says Anna-Karin Roberto. We are excited to embark on this journey together. Welcome to the Readily team, Anna-Karin! https://lnkd.in/dnFaNwed
News — Readily Diagnostics
readily.se
-
We are happy to welcome William Göransson as a new member of the Readily team! William takes the position of Research Engineer Production and brings great skills and knowledge in biotechnology and reagent manufacturing. William holds a M.Sc. in Molecular Biotechnology Engineering and is a valuable member in our R&D and our new Production team. "I am so excited that William is a part of Readily - with his skills he will contribute significantly to help Readily bring cost-effective diagnostics to the market. Welcome William to the family!", says CEO Liza Löf (Mokvist).
-
-
We are indeed excited! This will help us move faster towards bringing diagnostics to where it is needed!
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Last in line to presented is the company Readily Diagnostics. Readily Diagnostics' technology is based on padlock probes and rolling circle amplification (RCA), combined with a proprietary solution to enhance speed. It integrates a molecular method with microfluidics, allowing for use in various settings or with standard laboratory equipment for high throughput. This technology offers the robustness and specificity of RT-PCR without requiring specialized instruments. "We are incredibly excited and honored to have been selected for the BIO-X Accelerate program! We see this as validation that our diagnostic tests will make a significant difference in healthcare. With the support of BIO-X Accelerate, we can now take further steps to develop our clinical test, advance our regulatory journey towards CE-IVD certification, and offer it to healthcare providers more quickly." — Liza Löf (Mokvist), PhD, CEO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Readily Diagnostics and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
Liknande sidor
Finansiering
Readily Diagnostics
1 runda totalt
Se mer info på crunchbase
Senaste finansieringsrunda
Kapital
Extern Crunchbase Link för sista finansieringsrundan
1 737 306,00 US$